Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma

Publisher： Karger

E-ISSN： 1421-9794|55|4|221-227

ISSN： 0009-3157

Source： Chemotherapy, Vol.55, Iss.4, 2009-05, pp. : 221-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Trial of Gemcitabine in the Treatment of Advanced Bile Duct and Periampullary Carcinomas

By  

Chemotherapy, Vol. 49, Iss. 3, 2003-06 ,pp. : 154-158

Karger

Access to resources Recommend Favorite

Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Orally Administered Rapamycin, Dacarbazine or Both for Treatment of Human Melanoma Evaluated in Severe Combined Immunodeficiency Mice

By  

Pharmacology, Vol. 82, Iss. 3, 2008-09 ,pp. : 233-238

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer

By  

Chemotherapy, Vol. 56, Iss. 2, 2010-03 ,pp. : 94-100

Karger

Access to resources Recommend Favorite